Show simple item record

dc.contributor.authorMcInnerney, Den_US
dc.contributor.authorChung, Den_US
dc.contributor.authorMughal, Men_US
dc.contributor.authorOnifade, Aen_US
dc.contributor.authorHolden, Den_US
dc.contributor.authorGoodman, Jen_US
dc.contributor.authorBirchall, Men_US
dc.contributor.authorPeake, MDen_US
dc.contributor.authorQuaife, SLen_US
dc.date.accessioned2023-04-25T10:44:12Z
dc.date.issued2023-04-19en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/85980
dc.description.abstractINTRODUCTION: In the UK, the National Cancer Plan (2000) requires every cancer patient's care to be reviewed by a multidisciplinary team (MDT). Since the introduction of these guidelines, MDTs have faced escalating demands with increasing numbers and complexity of cases. The COVID-19 pandemic has presented MDTs with the challenge of running MDT meetings virtually rather than face-to-face.This study aims to explore how the change from face-to-face to virtual MDT meetings during the COVID-19 pandemic may have impacted the effectiveness of decision-making in cancer MDT meetings and to make recommendations to improve future cancer MDT working based on the findings. METHODS AND ANALYSIS: A mixed-methods study with three parallel phases:Semistructured remote qualitative interviews with ≤40 cancer MDT members.A national cross-sectional online survey of cancer MDT members in England, using a validated questionnaire with both multiple-choice and free-text questions.Live observations of ≥6 virtual/hybrid cancer MDT meetings at four NHS Trusts.Participants will be recruited from Cancer Alliances in England. Data collection tools have been developed in consultation with stakeholders, based on a conceptual framework devised from decision-making models and MDT guidelines. Quantitative data will be summarised descriptively, and χ2 tests run to explore associations. Qualitative data will be analysed using applied thematic analysis. Using a convergent design, mixed-methods data will be triangulated guided by the conceptual framework.The study has been approved by NHS Research Ethics Committee (London-Hampstead) (22/HRA/0177). The results will be shared through peer-reviewed journals and academic conferences. A report summarising key findings will be used to develop a resource pack for MDTs to translate learnings from this study into improved effectiveness of virtual MDT meetings.The study has been registered on the Open Science Framework (https://doi.org/10.17605/OSF.IO/D2NHW).en_US
dc.format.extente064911 - ?en_US
dc.languageengen_US
dc.relation.ispartofBMJ Openen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subjectCOVID-19en_US
dc.subjectHEALTH SERVICES ADMINISTRATION & MANAGEMENTen_US
dc.subjectONCOLOGYen_US
dc.subjectTelemedicineen_US
dc.subjectHumansen_US
dc.subjectCOVID-19en_US
dc.subjectCross-Sectional Studiesen_US
dc.subjectPandemicsen_US
dc.subjectNeoplasmsen_US
dc.subjectPatient Care Teamen_US
dc.titleChanging from face-to-face to virtual meetings due to the COVID-19 pandemic: protocol for a mixed-methods study exploring the impact on cancer multidisciplinary team (MDT) meetings.en_US
dc.typeArticle
dc.identifier.doi10.1136/bmjopen-2022-064911en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/37076166en_US
pubs.issue4en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume13en_US
qmul.funderCancer multi-disciplinary team (MDT) meetings during the COVID-19 pandemic::University College London Hospital NHS Trusten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial 3.0 United States